After CAPRISA 004: time to re-evaluate the HIV lexicon.
Cates
Willard
W
FHI, Research Triangle Park, NC 27709, USA. wcates@fhi.org
D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000282:Administration, Intravaginal; D000284:Administration, Oral; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D005260:Female; D005782:Gels; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D063065:Organophosphonates / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage*; D000068698:Tenofovir
D019380:Anti-HIV Agents; D005782:Gels; D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D000068698:Tenofovir; D000225:Adenine